Radiotherapy as adjuvant treatment after total hysterectomy has proven to be effective in lowering cancer-specific mortality rate.1 However, traditional three-dimensional conformal radiotherapy (3D-CRT) as adjuvant treatment after total hysterectomy is associated with a series of late gastrointestin

Prostate cancer was the third most common cancer among males in Hong Kong in 2018, accounting for 12.9% of total cancer cases and 5.5% of total cancer deaths.1 For decades, the anatomical extent or stage of cancer has been classified using the tumor-node-metastasis (TNM) system, but not for localize

A newly published clinical practice guideline in the Journal of Clinical Endocrinology & Metabolism provided the latest evidence-based guidance on the management of dyslipidemia and the reduction of atherosclerotic cardiovascular disease (ASCVD) risk in patients with various kinds of endocrine disea

Canagliflozin is the first sodium-glucose co-transporter 2 (SGLT2) inhibitor approved for the treatment of type 2 diabetes.1 Although canagliflozin offers benefits such as reductions in body weight, blood pressure, and risk for hypoglycemia,2 the US Food and Drug Administration (FDA) has included a

As suggested by the observational studies from Italy and France presented at the Virtual Annual Congress of the European Academy of Dermatology and Venereology, biologic therapy for psoriasis may be protective to infected patients against severe and fatal COVID-19 although such protective benefit do